Table 3 LN+ rate and age within T-stage groups
Age, | T2 | T3 | T4 | |||
|---|---|---|---|---|---|---|
years | All patients | LN+ (%) | All patients | LN+ (%) | All patients | LN+ (%) |
All | 6353 | 786 (12.37) | 6479 | 2247 (34.68) | 2792 | 1288 (46.13) |
< 50 | 331 | 52 (15.71) | 281 | 112 (39.86) | 135 | 71 (52.59) |
50–59 | 1138 | 156 (13.71) | 1034 | 418 (40.43) | 442 | 228 (51.58) |
60–69 | 2141 | 281 (13.12) | 1897 | 710 (37.43) | 876 | 406 (46.35) |
70–79 | 2053 | 232 (11.30) | 2230 | 670 (30.04) | 942 | 411 (43.63) |
≥80 | 690 | 65 (9.42) | 1037 | 337 (32.50) | 397 | 172 (43.32) |
P* | 0.01 | < 0.001 | 0.03 | |||